​

Merck (MRK) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

MRK Stock Forecast

Merck (MRK) stock forecast, based on 37 Wall Street analysts, predicts a 12-month average price target of $140.64, with a high of $155.00 and a low of $105.00. This represents a 9.39% increase from the last price of $128.57.

$95 $107 $119 $131 $143 $155 High: $155 Avg: $140.64 Low: $105 Last Closed Price: $128.57

MRK Stock Rating

Merck stock's rating consensus is Buy, based on 37 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 25 Buy (67.57%), 11 Hold (29.73%), 1 Sell (2.70%), and 0 Strong Sell (0.00%).

Buy
Total 37 1 11 25 Strong Sell Sell Hold Buy Strong Buy

MRK Price Target Upside V Benchmarks

TypeNameUpside
StockMerck9.39%
SectorHealthcare Stocks 15.45%
IndustryDrug Manufacturers - General Stocks10.09%

Price Target Trends

1M3M12M
# Anlaysts61029
Avg Price Target$134.00$139.00$128.72
Last Closing Price$128.57$128.57$128.57
Upside/Downside4.22%8.11%0.12%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Aug, 264158-128
Jul, 264159-129
Jun, 2641510--29
May, 2641510--29
Apr, 2641411--29
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 05, 2026Terence FlynnMorgan Stanley$116.00$130.40-11.04%-9.78%
Aug 05, 2026Vamil DivanGuggenheim$146.00$128.0414.03%13.56%
Jul 29, 2026Emily FieldBarclays$150.00$131.8413.77%16.67%
Jul 27, 2026Courtney BreenBernstein$105.00$132.34-20.66%-18.33%
Jul 13, 2026BMO Capital$142.00$124.0814.44%10.45%
Jul 13, 2026Vamil DivanGuggenheim$145.00$123.5417.37%12.78%
Jul 06, 2026Rajesh KumarHSBC$150.00$126.0519.00%16.67%
Jun 30, 2026Jefferies$141.00$129.388.98%9.67%
Jun 29, 2026Scotiabank$155.00$129.3819.80%20.56%
Jun 02, 2026Vamil DivanGuggenheim$140.00$115.2121.52%8.89%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Aug 05, 2026GuggenheimBuyBuyhold
Jul 29, 2026BarclaysOverweightOverweighthold
Jul 27, 2026BernsteinMarket PerformMarket Performhold
Jul 13, 2026BMO CapitalOutperformOutperformhold
Jul 13, 2026GuggenheimBuyBuyhold
Jul 08, 2026Wells FargoOverweightOverweighthold
Jul 06, 2026HSBCBuyBuyhold
Jun 30, 2026CitigroupBuyBuyhold
Jun 30, 2026Bank of America SecuritiesBuyBuyhold
Jun 29, 2026ScotiabankOutperformOutperformhold

Financial Forecast

EPS Forecast

$0 $3 $6 $9 $12 $15 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$5.16$5.73$0.14$6.76$7.28---
Avg Forecast$5.79$7.39$1.38$7.76$9.23$10.03$10.74$10.74
High Forecast$5.96$7.71$1.46$7.87$10.03$11.36$12.56$11.28
Low Forecast$5.63$7.17$1.33$7.64$7.89$8.36$8.52$10.51
Surprise %-10.88%-22.46%-89.86%-12.89%-21.13%---

Revenue Forecast

$45B $52B $59B $66B $73B $80B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$48.70B$59.28B$60.12B$64.17B$65.01B---
Avg Forecast$48.52B$59.12B$59.97B$63.99B$67.11B$70.95B$74.43B$75.50B
High Forecast$49.59B$61.06B$60.30B$64.28B$68.80B$71.14B$74.90B$78.42B
Low Forecast$47.46B$57.78B$59.81B$63.75B$66.44B$70.77B$73.97B$74.24B
Surprise %0.38%0.27%0.24%0.28%-3.12%---

Net Income Forecast

$0 $7B $14B $21B $28B $35B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$13.05B$14.52B$365.00M$17.12B$18.25B---
Avg Forecast$12.27B$14.91B$365.00M$19.76B$21.95B$24.45B$26.84B$27.37B
High Forecast$14.72B$17.89B$438.00M$20.06B$25.55B$28.92B$32.00B$28.74B
Low Forecast$9.81B$11.93B$292.00M$19.46B$20.09B$21.30B$21.71B$26.77B
Surprise %6.36%-2.62%--13.37%-16.86%---

MRK Forecast FAQ

Is Merck stock a buy?

Merck stock has a consensus rating of Buy, based on 37 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 25 Buy, 11 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Merck is a favorable investment for most analysts.

What is Merck's price target?

Merck's price target, set by 37 Wall Street analysts, averages $140.64 over the next 12 months. The price target range spans from $105 at the low end to $155 at the high end, suggesting a potential 9.39% change from the previous closing price of $128.57.

How does Merck stock forecast compare to its benchmarks?

Merck's stock forecast shows a 9.39% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the drug manufacturers - general stocks industry (10.09%).

What is the breakdown of analyst ratings for Merck over the past three months?

  • August 2026: 14.29% Strong Buy, 53.57% Buy, 28.57% Hold, 0% Sell, 3.57% Strong Sell.
  • July 2026: 13.79% Strong Buy, 51.72% Buy, 31.03% Hold, 0% Sell, 3.45% Strong Sell.
  • June 2026: 13.79% Strong Buy, 51.72% Buy, 34.48% Hold, 0% Sell, 0% Strong Sell.

What is Merck’s EPS forecast?

Merck's average annual EPS forecast for its fiscal year ending in December 2026 is $10.03, marking a 37.77% increase from the reported $7.28 in 2025. Estimates for the following years are $10.74 in 2027, and $10.74 in 2028.

What is Merck’s revenue forecast?

Merck's average annual revenue forecast for its fiscal year ending in December 2026 is $70.95B, reflecting a 9.14% increase from the reported $65.01B in 2025. The forecast for 2027 is $74.43B, and $75.5B for 2028.

What is Merck’s net income forecast?

Merck's net income forecast for the fiscal year ending in December 2026 stands at $24.45B, representing an 33.93% increase from the reported $18.25B in 2025. Projections indicate $26.84B in 2027, and $27.37B in 2028.